Newsletter insight
Chinese Brain-Computer Interface Startup NeuroXess Raises US$96.6 Million
Perspectives from the HPC business newsletter.
← All business news
On 28 October 2026, China-based NeuroXess secured approximately US$96.6 million in a Series B funding round. The company develops implantable brain-computer interface technology, with the funding expected to support clinical trials, regulatory submissions,...
On 28 October 2026, China-based NeuroXess secured approximately US$96.6 million in a Series B funding round. The company develops implantable brain-computer interface technology, with the funding expected to support clinical trials, regulatory submissions, manufacturing expansion and further product development.
The investment creates opportunities for medical research institutions, specialist hospitals, clinical technology providers and healthcare investors. HPC can support organisations with medical-data processing, AI research, clinical simulations and secure healthcare computing infrastructure.